R01 AI148560/AI/NIAID NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2020	7
2021	7
2022	3
2023	1
2024	3

1

Therapeutic Options for Metallo-β-Lactamase-Producing Enterobacterales.

Tan X, Kim HS, Baugh K, Huang Y, Kadiyala N, Wences M, Singh N, Wenzler E, Bulman ZP. Tan X, et al. Infect Drug Resist. 2021 Jan 18;14:125-142. doi: 10.2147/IDR.S246174. eCollection 2021. Infect Drug Resist. 2021. PMID: 33500635 Free PMC article. Review.

2

Research priorities towards precision antibiotic therapy to improve patient care.

Bulman ZP, Wicha SG, Nielsen EI, Lenhard JR, Nation RL, Theuretzbacher U, Derendorf H, Tängdén T, Zeitlinger M, Landersdorfer CB, Bulitta JB, Friberg LE, Li J, Tsuji BT; International Society of Anti-Infective Pharmacology; European Society of Clinical Microbiology and Infectious Diseases Pharmacokinetics and Pharmacodynamics of Anti-Infectives Study Group; International Society of Antimicrobial Chemotherapy Anti-Infective Pharmacology Working Group. Bulman ZP, et al. Lancet Microbe. 2022 Oct;3(10):e795-e802. doi: 10.1016/S2666-5247(22)00121-5. Epub 2022 Jun 28. Lancet Microbe. 2022. PMID: 35777386 Free article. Review.

3

Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision.

Chua HC, Tse A, Smith NM, Mergenhagen KA, Cha R, Tsuji BT. Chua HC, et al. Int J Antimicrob Agents. 2021 Mar;57(3):106269. doi: 10.1016/j.ijantimicag.2020.106269. Epub 2020 Dec 23. Int J Antimicrob Agents. 2021. PMID: 33358761 Review.

4

In vitro Optimization of Ceftazidime/Avibactam for KPC-Producing Klebsiella pneumoniae.

Huang Y, Wu T, Perez O, Rana AP, Chen L, Kreiswirth BN, Satlin MJ, Bulman ZP. Huang Y, et al. Front Microbiol. 2021 Mar 4;12:618087. doi: 10.3389/fmicb.2021.618087. eCollection 2021. Front Microbiol. 2021. PMID: 33763041 Free PMC article.

5

Ceftazidime-avibactam based combinations against carbapenemase producing Klebsiella pneumoniae harboring hypervirulence plasmids.

Bulman ZP, Tan X, Chu TY, Huang Y, Rana AP, Singh N, Flowers SA, Kyono Y, Kreiswirth BN, Chen L. Bulman ZP, et al. Comput Struct Biotechnol J. 2022 Jul 15;20:3946-3954. doi: 10.1016/j.csbj.2022.07.017. eCollection 2022. Comput Struct Biotechnol J. 2022. PMID: 35950190 Free PMC article.

6

Next generation antibiotic combinations to combat pan-drug resistant Klebsiella pneumoniae.

Kaur JN, Singh N, Smith NM, Klem JF, Cha R, Lang Y, Chen L, Kreiswirth B, Holden PN, Bulitta JB, Tsuji BT. Kaur JN, et al. Sci Rep. 2024 Feb 7;14(1):3148. doi: 10.1038/s41598-024-53130-z. Sci Rep. 2024. PMID: 38326428 Free PMC article.

7

Capability of Enterococcus faecalis to shield Gram-negative pathogens from aminoglycoside exposure.

McMurtry TA, Barekat A, Rodriguez F, Purewal P, Bulman ZP, Lenhard JR. McMurtry TA, et al. J Antimicrob Chemother. 2021 Sep 15;76(10):2610-2614. doi: 10.1093/jac/dkab211. J Antimicrob Chemother. 2021. PMID: 34245262 Free PMC article.

8

Polymyxin Triple Combinations against Polymyxin-Resistant, Multidrug-Resistant, KPC-Producing Klebsiella pneumoniae.

Aye SM, Galani I, Yu H, Wang J, Chen K, Wickremasinghe H, Karaiskos I, Bergen PJ, Zhao J, Velkov T, Giamarellou H, Lin YW, Tsuji BT, Li J. Aye SM, et al. Antimicrob Agents Chemother. 2020 Jul 22;64(8):e00246-20. doi: 10.1128/AAC.00246-20. Print 2020 Jul 22. Antimicrob Agents Chemother. 2020. PMID: 32393492 Free PMC article.

9

Comprehensive stability analysis of 13 β-lactams and β-lactamase inhibitors in in vitro media, and novel supplement dosing strategy to mitigate thermal drug degradation.

Zhou J, Qian Y, Lang Y, Zhang Y, Tao X, Moya B, Sayed ARM, Landersdorfer CB, Shin E, Werkman C, Smith NM, Kim TH, Kumaraswamy M, Shin BS, Tsuji BT, Bonomo RA, Lee RE, Bulitta JB. Zhou J, et al. Antimicrob Agents Chemother. 2024 Mar 6;68(3):e0139923. doi: 10.1128/aac.01399-23. Epub 2024 Feb 8. Antimicrob Agents Chemother. 2024. PMID: 38329330

10

Informing and Validating Translational Mechanism-Based Models for Antibiotics by Experimental and Computational Approaches.

Bulitta JB. Bulitta JB. Clin Pharmacol Ther. 2021 Dec;110(6):1426-1428. doi: 10.1002/cpt.2367. Epub 2021 Sep 23. Clin Pharmacol Ther. 2021. PMID: 34555178 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

19 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year